China’s ABclonal bags $189m in Series D funding co-led by Sequoia Capital China

China’s ABclonal bags $189m in Series D funding co-led by Sequoia Capital China

Life Science

Liya Su

09 December, 2021

ABclonal TechnologySequoia Capital China

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter

You may also like

Read more from Greater China

Nikkei Logo
DealStreetAsia Logo
About Us
Team
Advertise
Contact
Careers
Blog
Privacy Policy
Terms & Conditions
© Copyright DEALSTREETASIA 2014-2025 All rights reserved.